They found that the fetal breast stem cells are sensitive to a class of targeted therapies that already exists, so these therapies might also work in triple negative breast cancers. (salk.edu)
The researchers studied triple - negative breast cancer cells, which grow and spread faster than most other types of cancer cells. (sciencedaily.com)